Product NDC: | 0591-2224 |
Proprietary Name: | CycloSPORINE |
Non Proprietary Name: | CycloSPORINE |
Active Ingredient(s): | 100 mg/mL & nbsp; CycloSPORINE |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-2224 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065054 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081201 |
Package NDC: | 0591-2224-55 |
Package Description: | 1 BOTTLE in 1 BOX (0591-2224-55) > 50 mL in 1 BOTTLE |
NDC Code | 0591-2224-55 |
Proprietary Name | CycloSPORINE |
Package Description | 1 BOTTLE in 1 BOX (0591-2224-55) > 50 mL in 1 BOTTLE |
Product NDC | 0591-2224 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CycloSPORINE |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20081201 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | CYCLOSPORINE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |